Trial · NCT00433017
Adverse events182
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 182
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | CONJUNCTIVAL HAEMORRHAGE (Study eye) | Eye disorders | Verteporfin + Ranibizumab | 4 | 122 | |
| other | CONJUNCTIVAL HAEMORRHAGE (Study eye) | Eye disorders | Ranibizumab | 10 | 133 | |
| other | EYE PAIN (Study eye) | Eye disorders | Verteporfin + Ranibizumab | 10 | 122 | |
| other | EYE PAIN (Study eye) | Eye disorders | Ranibizumab | 8 | 133 | |
| other | MACULAR DEGENERATION (Fellow eye) | Eye disorders | Verteporfin + Ranibizumab | 4 | 122 | |
| other | MACULAR DEGENERATION (Fellow eye) | Eye disorders | Ranibizumab | 8 | 133 | |
| other | OCULAR HYPERAEMIA (Study eye) | Eye disorders | Verteporfin + Ranibizumab | 7 | 122 | |
| other | OCULAR HYPERAEMIA (Study eye) | Eye disorders | Ranibizumab | 10 | 133 | |
| other | RETINAL HAEMORRHAGE (Study eye) | Eye disorders | Verteporfin + Ranibizumab | 7 | 122 | |
| other | RETINAL HAEMORRHAGE (Study eye) | Eye disorders | Ranibizumab | 5 | 133 | |
| other | BRONCHITIS | Infections and infestations | Verteporfin + Ranibizumab | 5 | 122 | |
| other | BRONCHITIS | Infections and infestations | Ranibizumab | 7 | 133 | |
| other | INFLUENZA | Infections and infestations | Verteporfin + Ranibizumab | 3 | 122 | |
| other | INFLUENZA | Infections and infestations | Ranibizumab | 9 | 133 | |
| other | NASOPHARYNGITIS | Infections and infestations | Verteporfin + Ranibizumab | 18 | 122 | |
| other | NASOPHARYNGITIS | Infections and infestations | Ranibizumab | 15 | 133 | |
| other | INTRAOCULAR PRESSURE INCREASED (Study eye) | Investigations | Verteporfin + Ranibizumab | 11 | 122 | |
| other | INTRAOCULAR PRESSURE INCREASED (Study eye) | Investigations | Ranibizumab | 8 | 133 | |
| other | ARTHRALGIA | Musculoskeletal and connective tissue disorders | Verteporfin + Ranibizumab | 8 | 122 | |
| other | ARTHRALGIA | Musculoskeletal and connective tissue disorders | Ranibizumab | 3 | 133 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00433017/events